GlassScriptPhysician profile
Edward A Abell
NPI 1184733370
$5,243.31
in general payments reported to CMS, 2019-2025
28 companies · $646 in 2025
The $646 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $539 · 2021: $447 · 2022: $545 · 2023: $2,352 · 2024: $422 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,038 · Travel and Lodging: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,038.25 |
| Travel and Lodging | $1,381.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,503.70 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps, Botox |
| Allergan, INC. | $681.18 | 2019-2022 | |
| Integra Lifesciences Corporation | $377.70 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Smith+Nephew, INC. | $321.39 | 2019-2024 | Stravix, Grafix Pl, Vlp Mini-Mod |
| Musculoskeletal Transplant Foundation INC. | $187.83 | 2019-2021 | |
| Mentor Worldwide LLC | $178.48 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Axogen | $172.32 | 2019-2025 | |
| Revance Therapeutics, INC. | $131.12 | 2024-2025 | Daxxify |
| Depuy Synthes Sales INC. | $130.11 | 2020-2021 | |
| Davol INC. | $87.93 | 2022-2024 | Phasix Mesh, Arista Ah Flexitip |
| Vertex Pharmaceuticals Incorporated | $76.11 | 2024-2025 | |
| Polynovo North America LLC | $53.03 | 2022-2023 | |
| Rti Surgical, INC | $48.24 | 2023-2024 | |
| Tela Bio, INC. | $44.14 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Galderma Laboratories, L.P. | $40.54 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $33.53 | 2021-2022 | |
| Lifenet Health | $25.93 | 2025 | Theragenesis Wound Matrix |
| Boston Scientific Corporation | $20.84 | 2021 | |
| Next Science LLC | $16.91 | 2020 | |
| Baxter Healthcare | $16.70 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $15.10 | 2023 | Seglentis |
| Osiris Therapeutics INC. | $14.59 | 2019 | |
| Ethicon US, LLC | $13.59 | 2020 | |
| Coopersurgical, INC. | $12.80 | 2021 | |
| Medtronic, INC. | $11.76 | 2021 | |
| Aroa Biosurgery Incorporated | $11.48 | 2022 | |
| Sonex Health, INC. | $10.10 | 2024 | Sx-One Microknife |
| Reprise Biomedical, INC. | $6.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Abell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.